Last week, PureTech Health spun out a new company, Celea Therapeutics, which will develop its pulmonary fibrosis candidate ...

Denmark’s Novo Nordisk scored a significant regulatory win for GLP-1 drug Wegovy (semaglutide), as the US Food and Drug ...

Shares of New Jersey, USA-based Tonix Pharmaceuticals rose 15.5% to $59.31 in after-hours trading on Friday, after the ...

Costco (Nasdaq: COST) has confirmed it will not sell the abortion pill mifepristone, which is sold under the Mifeprex brand, ...

With help from artificial intelligence, Massachusetts Institute of Technology (MIT) researchers have designed novel ...

The US Department of Health and Human Services has reinstated the Task Force on Safer Childhood Vaccines, a panel created by ...

Flagship Pioneering has appointed Ajit Singh as chief executive (CEO)-partner of Flagship and the new CEO of Harbinger Health ...

A first-of-its-kind study from UK pharm major AstraZeneca and Macmillan Cancer Support into the barriers around access to the ...

Schrödinger (Nasdaq: SDGR) has halted the clinical development of its oral drug SGR-2921 following the occurrence of two ...

The Swiss government has met with senior executives from Roche (ROG: SIX) and Novartis (NOVN: VX) to discuss the outlook for ...

Eli Lilly (NYSE: LLY) has entered into a collaboration with Boston-based Superluminal Medicines to develop small-molecule ...

Swiss drug developer Basilea Pharmaceutica has entered into an exclusive license agreement with Venatorx Pharmaceuticals, to ...